Literature DB >> 24837468

Infants with acute myeloid leukemia treated according to the Associazione Italiana di Ematologia e Oncologia Pediatrica 2002/01 protocol have an outcome comparable to that of older children.

Riccardo Masetti1, Roberto Rondelli2, Franca Fagioli3, Angela Mastronuzzi4, Paolo Pierani5, Marco Togni2, Giuseppe Menna6, Martina Pigazzi7, Maria Caterina Putti7, Giuseppe Basso7, Andrea Pession2, Franco Locatelli8.   

Abstract

Entities:  

Keywords:  acute myeloid leukemia; hematopoietic stem cell transplantation; infants; intensive chemotherapy

Mesh：

Year:  2014        PMID： 24837468      PMCID： PMC4116842          DOI： 10.3324/haematol.2014.106526

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  11 in total

1.  Superior outcome of infant acute myeloid leukemia with intensive chemotherapy: results of the Japan Infant Leukemia Study Group.

Authors:  H Kawasaki; K Isoyama; M Eguchi; S Hibi; N Kinukawa; Y Kosaka; T Oda; M Oda; S Nishimura; M Imaizumi; T Okamura; T Hongo; H Okawa; S Mizutani; Y Hayashi; I Tsukimoto; N Kamada; E Ishii
Journal:  Blood       Date:  2001-12-15       Impact factor: 22.113

Review 2.  Infant acute lymphoblastic leukemia: Lessons learned and future directions.

Authors:  Rob Pieters
Journal:  Curr Hematol Malig Rep       Date:  2009-07       Impact factor: 3.952

3.  Favorable outcome in infants with AML after intensive first- and second-line treatment: an AML-BFM study group report.

Authors:  U Creutzig; M Zimmermann; J-P Bourquin; M N Dworzak; B Kremens; T Lehrnbecher; C von Neuhoff; A Sander; A von Stackelberg; I Schmid; J Starý; D Steinbach; J Vormoor; D Reinhardt
Journal:  Leukemia       Date:  2011-10-04       Impact factor: 11.528

Review 4.  Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel.

Authors:  Ursula Creutzig; Marry M van den Heuvel-Eibrink; Brenda Gibson; Michael N Dworzak; Souichi Adachi; Eveline de Bont; Jochen Harbott; Henrik Hasle; Donna Johnston; Akitoshi Kinoshita; Thomas Lehrnbecher; Guy Leverger; Ester Mejstrikova; Soheil Meshinchi; Andrea Pession; Susana C Raimondi; Lillian Sung; Jan Stary; Christian M Zwaan; Gertjan J L Kaspers; Dirk Reinhardt
Journal:  Blood       Date:  2012-08-09       Impact factor: 22.113

5.  Relationships between age at diagnosis, clinical features, and outcome of therapy in children treated in the Medical Research Council AML 10 and 12 trials for acute myeloid leukemia.

Authors:  D K Webb; G Harrison; R F Stevens; B G Gibson; I M Hann; K Wheatley
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

6.  NONMEM population pharmacokinetic studies of cytosine arabinoside after high-dose and after loading bolus followed by continuous infusion of the drug in pediatric patients with leukemias.

Authors:  A P Periclou; V I Avramis
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333

7.  Prognostic factors in infants with acute myeloid leukemia.

Authors:  C H Pui; S C Raimondi; D K Srivastava; X Tong; F G Behm; B Razzouk; J E Rubnitz; J T Sandlund; W E Evans; R Ribeiro
Journal:  Leukemia       Date:  2000-04       Impact factor: 11.528

8.  Treatment and long-term results in children with acute myeloid leukaemia treated according to the AIEOP AML protocols.

Authors:  A Pession; R Rondelli; G Basso; C Rizzari; A M Testi; F Fagioli; P De Stefano; F Locatelli
Journal:  Leukemia       Date:  2005-12       Impact factor: 11.528

9.  An Inv(16)(p13.3q24.3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia.

Authors:  Tanja A Gruber; Amanda Larson Gedman; Jinghui Zhang; Cary S Koss; Suresh Marada; Huy Q Ta; Shann-Ching Chen; Xiaoping Su; Stacey K Ogden; Jinjun Dang; Gang Wu; Vedant Gupta; Anna K Andersson; Stanley Pounds; Lei Shi; John Easton; Michael I Barbato; Heather L Mulder; Jayanthi Manne; Jianmin Wang; Michael Rusch; Swati Ranade; Ramapriya Ganti; Matthew Parker; Jing Ma; Ina Radtke; Li Ding; Giovanni Cazzaniga; Andrea Biondi; Steven M Kornblau; Farhad Ravandi; Hagop Kantarjian; Stephen D Nimer; Konstanze Döhner; Hartmut Döhner; Timothy J Ley; Paola Ballerini; Sheila Shurtleff; Daisuke Tomizawa; Souichi Adachi; Yasuhide Hayashi; Akio Tawa; Lee-Yung Shih; Der-Cherng Liang; Jeffrey E Rubnitz; Ching-Hon Pui; Elaine R Mardis; Richard K Wilson; James R Downing
Journal:  Cancer Cell       Date:  2012-11-13       Impact factor: 31.743

10.  CBFA2T3-GLIS2 fusion transcript is a novel common feature in pediatric, cytogenetically normal AML, not restricted to FAB M7 subtype.

Authors:  Riccardo Masetti; Martina Pigazzi; Marco Togni; Annalisa Astolfi; Valentina Indio; Elena Manara; Rita Casadio; Andrea Pession; Giuseppe Basso; Franco Locatelli
Journal:  Blood       Date:  2013-02-13       Impact factor: 22.113
View more
  9 in total

1.  Effect of age and body weight on toxicity and survival in pediatric acute myeloid leukemia: results from NOPHO-AML 2004.

Authors:  Ditte J A Løhmann; Jonas Abrahamsson; Shau-Yin Ha; Ólafur G Jónsson; Minna Koskenvuo; Birgitte Lausen; Josefine Palle; Bernward Zeller; Henrik Hasle
Journal:  Haematologica       Date:  2016-07-28       Impact factor: 9.941

2.  Gemtuzumab ozogamicin in infants with AML: results from the Children's Oncology Group trials AAML03P1 and AAML0531.

Authors:  Erin M Guest; Richard Aplenc; Lillian Sung; Susana C Raimondi; Betsy A Hirsch; Todd A Alonzo; Robert B Gerbing; Yi-Cheng Jim Wang; Samir B Kahwash; Amy Heerema-McKenney; Soheil Meshinchi; Alan S Gamis
Journal:  Blood       Date:  2017-07-03       Impact factor: 22.113

Review 3.  Acute Leukemia in Infants.

Authors:  Azada Ibrahimova; Lauren Pommert; Erin H Breese
Journal:  Curr Oncol Rep       Date:  2021-02-12       Impact factor: 5.075

Review 4.  Acute myeloid leukemia in infants: biology and treatment.

Authors:  Riccardo Masetti; Francesca Vendemini; Daniele Zama; Carlotta Biagi; Andrea Pession; Franco Locatelli
Journal:  Front Pediatr       Date:  2015-04-28       Impact factor: 3.418

Review 5.  Acute myeloid leukaemia at an early age: Reviewing the interaction between pesticide exposure and KMT2A-rearrangement.

Authors:  Maria S Pombo-de-Oliveira; Francianne Gomes Andrade; Gisele Dallapicola Brisson; Filipe Vicente Dos Santos Bueno; Ingrid Sardou Cezar; Elda Pereira Noronha
Journal:  Ecancermedicalscience       Date:  2017-11-30

6.  Unlike Its Paralog LEDGF/p75, HRP-2 Is Dispensable for MLL-R Leukemogenesis but Important for Leukemic Cell Survival.

Authors:  Siska Van Belle; Sara El Ashkar; Kateřina Čermáková; Filip Matthijssens; Steven Goossens; Alessandro Canella; Courtney H Hodges; Frauke Christ; Jan De Rijck; Pieter Van Vlierberghe; Václav Veverka; Zeger Debyser
Journal:  Cells       Date:  2021-01-19       Impact factor: 6.600

Review 7.  CBFA2T3-GLIS2-positive acute myeloid leukaemia. A peculiar paediatric entity.

Authors:  Riccardo Masetti; Salvatore N Bertuccio; Andrea Pession; Franco Locatelli
Journal:  Br J Haematol       Date:  2018-12-28       Impact factor: 6.998

8.  Is Acute Myeloblastic Leukemia in Children Under 2 Years of Age a Specific Entity? A Report from the FRENCH ELAM02 Study Group.

Authors:  S Blais; H Boutroux; M Pasquet; T Leblanc; O Fenneteau; V Gandemer; Y Bertrand; S Ducassou; G Michel; B Nelken; A Petit; W Cuccuini; E Gouache; Marceau-A Renaut; A Baruchel; H Lapillonne; G Leverger
Journal:  Hemasphere       Date:  2019-10-30

Review 9.  Insights on the Interplay between Cells Metabolism and Signaling: A Therapeutic Perspective in Pediatric Acute Leukemias.

Authors:  Laura Anselmi; Salvatore Nicola Bertuccio; Annalisa Lonetti; Arcangelo Prete; Riccardo Masetti; Andrea Pession
Journal:  Int J Mol Sci       Date:  2020-08-28       Impact factor: 5.923
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.